315228-51-4Relevant articles and documents
BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
-
Paragraph 1329-1330, (2019/05/15)
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor
THERAPEUTIC AGENTS FOR OCULAR HYPERTENSION
-
Page/Page column 10; 28; 29, (2012/01/15)
This invention provides well defined 6-alkyl or hydroxyalkyl-1-naphthamide or quinoline compounds for treating glaucoma or ocular hypertension.
Compounds for the modulation of PPARgamma activity
-
, (2008/06/13)
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.